vs

Side-by-side financial comparison of BrightView Holdings, Inc. (BV) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

BrightView Holdings, Inc. is the larger business by last-quarter revenue ($702.9M vs $665.5M, roughly 1.1× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs 0.2%, a 6.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 6.1%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -1.8%).

BrightView Holdings, Inc. is a leading US commercial landscaping services provider. It offers solutions including landscape design, installation, maintenance, irrigation management, and snow and ice removal, serving corporate campuses, retail centers, residential communities, and public sector properties.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

BV vs NTRA — Head-to-Head

Bigger by revenue
BV
BV
1.1× larger
BV
$702.9M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+33.7% gap
NTRA
39.8%
6.1%
BV
Higher net margin
NTRA
NTRA
6.9% more per $
NTRA
7.1%
0.2%
BV
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-1.8%
BV

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BV
BV
NTRA
NTRA
Revenue
$702.9M
$665.5M
Net Profit
$1.7M
$47.3M
Gross Margin
19.6%
Operating Margin
2.3%
-3.4%
Net Margin
0.2%
7.1%
Revenue YoY
6.1%
39.8%
Net Profit YoY
-73.4%
187.9%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BV
BV
NTRA
NTRA
Q2 26
$702.9M
Q1 26
$614.7M
Q4 25
$614.7M
$665.5M
Q3 25
$702.7M
$592.2M
Q2 25
$708.3M
$546.6M
Q1 25
$662.6M
$501.8M
Q4 24
$599.2M
$476.1M
Q3 24
$728.7M
$439.8M
Net Profit
BV
BV
NTRA
NTRA
Q2 26
$1.7M
Q1 26
Q4 25
$-15.2M
$47.3M
Q3 25
$27.7M
$-87.5M
Q2 25
$32.3M
$-100.9M
Q1 25
$6.4M
$-66.9M
Q4 24
$-10.4M
$-53.8M
Q3 24
$25.6M
$-31.6M
Gross Margin
BV
BV
NTRA
NTRA
Q2 26
19.6%
Q1 26
18.6%
Q4 25
18.6%
Q3 25
25.1%
Q2 25
24.1%
Q1 25
22.3%
Q4 24
21.2%
Q3 24
25.0%
Operating Margin
BV
BV
NTRA
NTRA
Q2 26
2.3%
Q1 26
Q4 25
-1.2%
-3.4%
Q3 25
7.9%
-16.5%
Q2 25
8.1%
-20.2%
Q1 25
3.4%
-15.8%
Q4 24
-0.1%
-13.6%
Q3 24
7.1%
-8.9%
Net Margin
BV
BV
NTRA
NTRA
Q2 26
0.2%
Q1 26
Q4 25
-2.5%
7.1%
Q3 25
3.9%
-14.8%
Q2 25
4.6%
-18.5%
Q1 25
1.0%
-13.3%
Q4 24
-1.7%
-11.3%
Q3 24
3.5%
-7.2%
EPS (diluted)
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
$-0.26
$0.36
Q3 25
$0.21
$-0.64
Q2 25
$0.15
$-0.74
Q1 25
$-0.03
$-0.50
Q4 24
$-0.20
$-0.41
Q3 24
$0.20
$-0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BV
BV
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$10.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
Total Assets
$3.4B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BV
BV
NTRA
NTRA
Q2 26
$10.1M
Q1 26
$37.0M
Q4 25
$37.0M
Q3 25
$74.5M
$1.0M
Q2 25
$79.1M
$16.0M
Q1 25
$141.3M
$17.8M
Q4 24
$98.3M
$22.7M
Q3 24
$140.4M
$29.5M
Total Debt
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
$801.1M
Q3 25
$790.2M
Q2 25
$790.7M
Q1 25
$798.9M
Q4 24
$796.5M
Q3 24
$802.5M
Stockholders' Equity
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
$1.3B
$1.7B
Q3 25
$1.3B
$1.3B
Q2 25
$1.3B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.3B
$1.2B
Q3 24
$1.3B
$878.5M
Total Assets
BV
BV
NTRA
NTRA
Q2 26
$3.4B
Q1 26
$3.3B
Q4 25
$3.3B
$2.4B
Q3 25
$3.4B
$1.8B
Q2 25
$3.4B
$1.8B
Q1 25
$3.3B
$1.7B
Q4 24
$3.3B
$1.7B
Q3 24
$3.4B
$1.6B
Debt / Equity
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
0.64×
Q3 25
0.61×
Q2 25
0.62×
Q1 25
0.63×
Q4 24
0.63×
Q3 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BV
BV
NTRA
NTRA
Operating Cash FlowLast quarter
$82.3M
$73.9M
Free Cash FlowOCF − Capex
$37.8M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
7.8%
5.4%
Cash ConversionOCF / Net Profit
48.41×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BV
BV
NTRA
NTRA
Q2 26
$82.3M
Q1 26
$36.1M
Q4 25
$36.1M
$73.9M
Q3 25
$84.4M
$59.4M
Q2 25
$55.7M
$37.6M
Q1 25
$91.2M
$44.5M
Q4 24
$60.5M
$52.9M
Q3 24
$53.5M
$51.8M
Free Cash Flow
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
$-18.6M
$37.8M
Q3 25
$26.0M
$37.0M
Q2 25
$-47.8M
$11.7M
Q1 25
$57.6M
$22.6M
Q4 24
$1.8M
$34.8M
Q3 24
$21.1M
$35.5M
FCF Margin
BV
BV
NTRA
NTRA
Q2 26
Q1 26
Q4 25
-3.0%
5.7%
Q3 25
3.7%
6.2%
Q2 25
-6.7%
2.1%
Q1 25
8.7%
4.5%
Q4 24
0.3%
7.3%
Q3 24
2.9%
8.1%
Capex Intensity
BV
BV
NTRA
NTRA
Q2 26
7.8%
Q1 26
7.9%
Q4 25
8.9%
5.4%
Q3 25
8.3%
3.8%
Q2 25
14.6%
4.7%
Q1 25
5.1%
4.3%
Q4 24
9.8%
3.8%
Q3 24
4.4%
3.7%
Cash Conversion
BV
BV
NTRA
NTRA
Q2 26
48.41×
Q1 26
Q4 25
1.56×
Q3 25
3.05×
Q2 25
1.72×
Q1 25
14.25×
Q4 24
Q3 24
2.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons